Search for Clinical Trial Results
Limited Cutaneous Systemic Sclerosis - 1 Studies Found
| Status | Study |
| Completed |
Study Name: Efficacy of Ambrisentan in Limited Scleroderma Patients in Improving Blood Flow to Hands or Feet Condition: Ischemia Date: 2010-02-19 Interventions: Drug: ambrisentan Subjects will receive ambrisentan 5 mg orally once daily or identical placebo pills fo |